718
Views
0
CrossRef citations to date
0
Altmetric
Acceptance & Hesitation

SARS-CoV-2 and influenza vaccine hesitancy during the COVID-19 pandemic in a dynamic perspective

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Article: 2358565 | Received 23 Jan 2024, Accepted 18 May 2024, Published online: 02 Jun 2024

References

  • U.S. Food and Drug Administration. COVID-19 vaccines. 2024 Apr 29. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines.
  • Petrova VN, Russell CA. The evolution of seasonal influenza viruses. Nat Rev Microbiol. 2018;16(1):47–11. doi:10.1038/nrmicro.2017.118.
  • Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close are countries of the WHO European region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine. 2018;36(4):442–52. doi:10.1016/j.vaccine.2017.12.019.
  • World Health Organization. Report of the strategic advisory group of experts on immunization working group on vaccine hesitancy. 2024 Apr 29. https://www.who.int/docs/default-source/immunization/demand/summary-of-sage-vaccinehesitancy-en.pdf?sfvrsn=abbfd5c8_2.
  • World Health Organization. Ten Threats to global health in 2019. 2024 Apr 29. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.
  • World Health Organization. Barriers of influenza vaccination intention and behavior: a systematic review of influenza vaccine hesitancy 2005–2016. 2016 [accessed 2024 Jan 23]. https://apps.who.int/iris/handle/10665/251671.
  • AlJamaan F, Temsah MH, Alhasan K, Alenezi S, Alhaboob A, Alrabiaah A, Batais M, Alshahrani F, Assiri RA, Bafaqih H. et al. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes. J Infect Public Health. 2022;15(7):773–80. doi:10.1016/j.jiph.2022.06.007.
  • Pertwee E, Simas C, Larson HJ. An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy. Nat Med. 2022;28(3):456–9. doi:10.1038/s41591-022-01728-z.
  • Domnich A, Cambiaggi M, Vasco A, Maraniello L, Ansaldi F, Baldo V, Bonanni P, Calabrò GE, Costantino C, de Waure C. et al. Attitudes and beliefs on influenza vaccination during the COVID-19 pandemic: results from a representative Italian survey. Vaccines. 2020;8(4):711. doi:10.3390/vaccines8040711.
  • Stefanizzi P, Bianchi FP, Brescia N, Ferorelli D, Tafuri S. Vaccination strategies between compulsion and incentives. The Italian green pass experience. Expert Rev Vaccines. 2022;21(4):423–5. doi:10.1080/14760584.2022.2023012.
  • Italian Ministry of Health. Public health Italy. 2024 Apr 29. https://www.salute.gov.it/portale/home.html.
  • Commissario straordinario per l’emergenza COVID-19 - Presidenza del Consiglio dei Ministri. COVID-19 opendata vaccini. 2024 Apr 29. https://github.com/italia/covid19-opendata-vaccini.
  • European Parliament. Regulation (EU) 2021/953 of the European parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic. 2021 [2024 Apr 29]. http://data.europa.eu/eli/reg/2021/953/oj.
  • De Giorgio A, Kuvačić G, Maleš D, Vecchio I, Tornali C, Ishac W, Ramaci T, Barattucci M, Milavić B. Willingness to receive COVID-19 booster vaccine: associations between green-pass, social media information, anti-vax beliefs, and emotional balance. Vaccines. 2022;10(3):481. doi:10.3390/vaccines10030481.
  • Italian Government. Decreto-legge 24 marzo 2022 Misure urgenti per il superamento delle misure di contrasto alla diffusione dell’epidemia da COVID-19, in conseguenza della cessazione dello stato di emergenza. 2022 [accessed 2024 Apr 29]. https://www.gazzettaufficiale.it/eli/id/2022/03/24/22G00034/sg.
  • Italian Government. Report vaccini anti-COVID-19. 2024 Apr 29. https://www.governo.it/it/cscovid19/report-vaccini/.
  • Istituto Superiore di Sanità. Le vaccinazioni in Italia. 2024 Apr 29. https://www.epicentro.iss.it/vaccini/dati_Ita#flu.
  • Italian Ministry of Health. Vaccinazione antinfluenzale. Tavole. 2024 Apr 29. https://www.salute.gov.it/imgs/C_17_tavole_19_3_1_file.pdf.
  • Peghin M, Bouza E, Fabris M, De Martino M, Palese A, Bontempo G, Graziano E, Gerussi V, Bressan V, Sartor A. et al. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40(12):2597–604. doi:10.1007/s10096-021-04335-x.
  • Gerussi V, Peghin M, Palese A, Bressan V, Visintini E, Bontempo G, Graziano E, De Martino M, Isola M, Tascini C. et al. Vaccine hesitancy among Italian patients recovered from COVID-19 infection towards Influenza and Sars-Cov-2 vaccination. Vaccines. 2021;9(2):9. doi:10.3390/vaccines9020172.
  • Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9:698111. doi:10.3389/fpubh.2021.698111.
  • Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nursing & Health Sciences. 2013;15(3):398–405. doi:10.1111/nhs.12048.
  • Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44. doi:10.1016/s1473-3099(11)70295-x.
  • Giacomelli A, Galli M, Maggi S, Noale M, Trevisan C, Pagani G, Antonelli-Incalzi R, Molinaro S, Bastiani L, Cori L. et al. Influenza vaccination uptake in the general Italian population during the 2020–2021 flu season: data from the EPICOVID-19 online web-based survey. Vaccines. 2022;10(2):293. doi:10.3390/vaccines10020293.
  • Lorini C, Lastrucci V, Zanella B, Gori E, Chiesi F, Bechini A, Boccalini S, Del Riccio M, Moscadelli A, Puggelli F. et al. Predictors of influenza vaccination uptake and the role of health literacy among health and social care volunteers in the province of Prato (Italy). Int J Environ Res And Public Health. 2022;19(11):6688. doi:10.3390/ijerph19116688.
  • World Health Organization. Regional office for Europe. Methods for assessing influenza vaccination coverage in target groups. 2016 [accessed 2024 Apr 29]. https://apps.who.int/iris/handle/10665/345696.
  • Harris JA, Moniz M, Lott B, Power R, Griggs JJ. Obesity and the receipt of influenza and pneumococcal vaccination: a systematic review and meta-analysis. BMC Obes. 2016;3(1):24. doi:10.1186/s40608-016-0105-5.
  • Kharroubi G, Cherif I, Bouabid L, Gharbi A, Boukthir A, Ben Alaya N, Ben Salah A, Bettaieb J. Influenza vaccination knowledge, attitudes, and practices among Tunisian elderly with chronic diseases. BMC Geriatr. 2021;21(1):700. doi:10.1186/s12877-021-02667-z.
  • Cori L, Curzio O, Adorni F, Prinelli F, Noale M, Trevisan C, Fortunato L, Giacomelli A, Bianchi F. Fear of COVID-19 for individuals and family members: indications from the national cross-sectional study of the EPICOVID19 web-based survey. Int J Environ Res And Public Health. 2021;18(6):3248. doi:10.3390/ijerph18063248.
  • Montalti M, Di Valerio Z, Rallo F, Squillace L, Costantino C, Tomasello F, Mauro GL, Stillo M, Perrone P, Resi D. et al. Attitudes toward the SARS-CoV-2 and influenza vaccination in the metropolitan cities of Bologna and Palermo, Italy. Nato Adv Sci Inst Se. 2021;9(10):1200. doi:10.3390/vaccines9101200.
  • Langer R, Thanner M. Pharmacists’ attitudes toward influenza vaccination: does the COVID-19 pandemic make a difference? Explor Res Clin Soc Pharm. 2023;9:100235. doi:10.1016/j.rcsop.2023.100235.
  • Arda B, Durusoy R, Yamazhan T, Sipahi OR, Taşbakan M, Pullukçu H, Erdem E, Ulusoy S. Did the pandemic have an impact on influenza vaccination attitude? A survey among health care workers. BMC Infect Dis. 2011;11(1):87. doi:10.1186/1471-2334-11-87.
  • Kwong EW, Lam IO, Chan TM. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? J Clin Nurs. 2009;18:960–71. doi:10.1111/j.1365-2702.2008.02548.x.
  • McIntyre A, Zecevic A, Diachun L. Influenza vaccinations: older adults’ decision-making process. Can J Aging. 2014;33(1):92–8. doi:10.1017/s0714980813000640.
  • Lazarus JV, Wyka K, White TM, Picchio CA, Gostin LO, Larson HJ, Rabin K, Ratzan SC, Kamarulzaman A, El-Mohandes A. et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat Med. 2023;29(2):366–75. doi:10.1038/s41591-022-02185-4.
  • Jones N. How COVID-19 is changing the cold and flu season. Nature. 2020;588(7838):388–90. doi:10.1038/d41586-020-03519-3.
  • Mills MC, Rüttenauer T. The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries. Lancet Public Health. 2022;7(1):15–22. doi:10.1016/s2468-2667(21)00273-5.
  • Moccia G, Carpinelli L, Savarese G, De Caro F. Vaccine hesitancy and the green digital pass: a study on adherence to the Italian COVID-19 vaccination campaign. Int J Environ Res And Public Health. 2022;19(5):2970. doi:10.3390/ijerph19052970.
  • Bell ML, Kenward MG, Fairclough DL, Horton NJ. Differential dropout and bias in randomised controlled trials: when it matters and when it may not. BMJ (Clin Res Ed). 2013;346(1):e8668. doi:10.1136/bmj.e8668.
  • Deml MJ, Githaiga JN. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review. BMJ Open. 2022;12(11):e066615. doi:10.1136/bmjopen-2022-066615.